09/12/2022
DIAN Diagnostics (China stock market code: 300244) has been appointed as the Official Exclusive Supplier of health testing related services for the 19th Asian Games and the 4th Asian Para Games in Hangzhou 2022.
As a comprehensive medical diagnostics service provider, DIAN Diagnostics established 40 chain laboratories and served 20 thousand+ medical institutions and over 460 million people. To fulfil the mission of achieving "Equal Access to Healthcare". DIAN Diagnostics is committed to play an active role in COVID-19 diagnosis and outbreak prevention with its accumulated over 25 years` experience in healthcare industry.
In abroad, DIAN Biotechnology (brand: GENEDIAN), an innovative IVD company and wholly owned subsidiary of DIAN Diagnostics, is providing integrated solutions to combat SARS-CoV-2 with COVID-19 Antigen Rapid Test Cassette, both Professional Use and Self-Testing, as well as Real Time PCR Detection systems for worldwide health concerns.
